MetaCap

Lantern Pharma (LTRN) vs Pulmatrix (PULM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Pulmatrix is the larger company by market cap ($4.6 million vs $3.9 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

LTRN-73.08%PULM-14.77%
+9%-34%-77%
Oct 7, 20261 yearNov 20, 2026
LTRN-69.85%PULM-13.01%
+5%-34%-73%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

LTRN versus PULM key metrics
MetricLTRNPULM
Share price$0.245$1.27
Market cap$3.89M$4.64M
1-day change-13.73%-10.56%
YTD return-91.91%—
1-year return-91.89%—
5-year return-97.27%—
EPS (TTM)$-1.44$-1.20
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-17.12M$-5.16M
52-week high$4.34$4.94
52-week low$0.2286$1.06
Distance from 52-week high-94.35%-74.29%
Analyst consensusnone—
Avg. price target upside+7042.86%—
Average volume249.66K35.45K
Shares outstanding15.89M3.65M
Employees162
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Lantern Pharma

LTRN stock →

Lantern Pharma Inc. focuses on the discovery and development of oncology drug in India.

Health Care · Biotechnology: Pharmaceutical Preparations · 16 employees

About Pulmatrix

PULM stock →

Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.

Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees

LTRN vs PULM FAQ

Which is bigger, Lantern Pharma or Pulmatrix?

Pulmatrix (PULM) is larger, with a market capitalization of $4.64M compared with $3.89M for Lantern Pharma (LTRN).

Are Lantern Pharma and Pulmatrix in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons